The central hypotheses are: 1) MICs drive the development of multiple myeloma; and 2) the SDF1-centric bio-physical and chemical positive feedback loop boosts MIC growth and colonogenesis, and protects MICs from drug treatments. Here, CXCL12 is linked to AL amyloidosis.